A multilocus genotyping assay for candidate markers of cardiovascular disease risk

被引:186
作者
Cheng, S [1 ]
Grow, MA
Pallaud, C
Klitz, W
Erlich, HA
Visvikis, S
Chen, JJ
Pullinger, CR
Malloy, MJ
Siest, G
Kane, JP
机构
[1] Roche Mol Syst Inc, Dept Human Genet, Alameda, CA 94501 USA
[2] Ctr Med Prevent, F-54501 Vandoeuvre Les Nancy, France
[3] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA
[4] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
关键词
D O I
10.1101/gr.9.10.936
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of chronic diseases, including cardiovascular disease, appear to have a multifactorial generic risk component. Consequently, techniques are needed to facilitate evaluation of complex genetic risk factors in large cohorts. We have designed a prototype assay For genotyping a panel of 35 biallelic sites that represent variation within 15 genes from biochemical pathways implicated in the development and progression of cardiovascular disease. Each DNA sample is amplified using two multiplex polymerase chain reactions, and the alleles are genotyped simultaneously using an array of immobilized, sequence-specific oligonucleotide probes. This multilocus assay was applied to two types of cohorts. Population frequencies For the markers were estimated using 496 unrelated individuals from a Family-based cohort, and the observed values were consistent with precious reports. Linkage disequilibrium between consecutive pairs of markers within the apoCIII, LPL, and ELAM genes was also estimated. A preliminary analysis of single and pairwise locus associations with severity of atherosclerosis was performed using a composite cohort of 142 individuals For whom quantitative angiography data were available; evaluation of the potentially interesting associations observed will require analysis of an independent and larger cohort. This assay format provides a research tool for studies of multilocus genetic risk factors in large cardiovascular disease cohorts, and for the subsequent development of diagnostic tests.
引用
收藏
页码:936 / 949
页数:14
相关论文
共 108 条
[11]   Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase [J].
Clark, AG ;
Weiss, KM ;
Nickerson, DA ;
Taylor, SL ;
Buchanan, A ;
Stengård, J ;
Salomaa, V ;
Vartiainen, E ;
Perola, M ;
Boerwinkle, E ;
Sing, CF .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) :595-612
[12]   FIBRINOGEN AS A MAJOR RISK FACTOR IN CARDIOVASCULAR-DISEASE [J].
COOK, NS ;
UBBEN, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (11) :444-451
[13]   AN APOLIPOPROTEIN CIII HAPLOTYPE PROTECTIVE AGAINST HYPERTRIGLYCERIDEMIA IS SPECIFIED BY PROMOTER AND 3' UNTRANSLATED REGION POLYMORPHISMS [J].
DAMMERMAN, M ;
SANDKUIJL, LA ;
HALAAS, JL ;
CHUNG, W ;
BRESLOW, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4562-4566
[14]  
DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279
[15]  
Day INM, 1997, HUM MUTAT, V10, P116
[16]   GENETIC-HETEROGENEITY OF APOLIPOPROTEIN-E AND ITS INFLUENCE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS [J].
DEKNIJFF, P ;
VANDENMAAGDENBERG, AMJM ;
FRANTS, RR ;
HAVEKES, LM .
HUMAN MUTATION, 1994, 4 (03) :178-194
[17]  
DUPONT B, 1987, IMMUNOBIOLOGY HLA, V1
[18]   Ethnic variation and in vivo effects of the -93t->g promoter variant in the lipoprotein lipase gene [J].
Ehrenborg, E ;
Clee, SM ;
Pimstone, SN ;
Reymer, PWA ;
Benlian, P ;
Hoogendijk, CF ;
Davis, HJ ;
Bissada, N ;
Miao, L ;
Gagne, SE ;
Greenberg, LJ ;
Henry, R ;
Henderson, H ;
Ordovas, JM ;
Schaefer, EJ ;
Kastelein, JJP ;
Kotze, MJ ;
Hayden, MR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2672-2678
[19]  
EVANS AE, 1994, Q J MED, V87, P211
[20]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113